Source: Annual Congress 2011 - Severity, comorbidities and outcomes in community-acquired pneumonia



Rating:

Share or cite this content

Citations should be made in the following way:
S. Krüger, J. Kunde, O. Hartmann, N. Suttorp, G. Rohde, T. Welte (Aachen, Henningsdorf, Berlin, Hannover, Germany; Maastricht, Netherlands). Dysnatremia, vasopressin, atrial natriuretic peptide and mortality in community-acquired pneumonia – Results from the German competence network CAPNETZ. Eur Respir J 2011; 38: Suppl. 55, 4711

Member's Comments

No comment yet.

Related content which might interest you: Prohormones of adrenomedullin, atrial natriuretic peptide, vasopressin and endothelin to predict short- and long-term survival in community-acquired pneumonia – Results from the German competence network CAPNETZ Source: Annual Congress 2010 - Risk factors and outcomes in community-acquired pneumonia Year: 2010 Hyponatremia in community-acquired pneumonia due to increased vasopressin secretion – impact on mortality Source: Annual Congress 2009 - Impact of biomarkers in the management of community-acquired pneumonia Year: 2009 Pro-vasopressin (copeptin) in patients with community-acquired pneumonia – influence of antibiotic pre-treatment; results from the German competence network CAPNETZ Source: Annual Congress 2009 - Impact of biomarkers in the management of community-acquired pneumonia Year: 2009 Pro-atrial natriuretic peptide to predict short-term and long-term mortality in community-acquired pneumonia Source: Annual Congress 2008 - Treatment and outcome in hospitalised patients with community-acquired pneumonia Year: 2008 Significance of heart failure in patients with pneumonia – Comparison of BNP and echocardiography Source: Annual Congress 2010 - Treatment and risk factors in lower respiratory tract infections Year: 2010 Influence of antibiotic pre-treatment on pro-atrial natriuretic peptide in community-acquired pneumonia Source: Annual Congress 2008 - Diagnostic tests in lower respiratory tract infections Year: 2008 Pro-atrial natriuretic peptide and pro-vasopressin to predict severity and prognosis in community-acquired pneumonia Source: Eur Respir J 2007; 30: Suppl. 51, 481s Year: 2007 Pro-atrial natriuretic peptide and pro-vasopressin to predict short- and long-term survival in community-acquired pneumonia Source: Annual Congress 2009 - Impact of biomarkers in the management of community-acquired pneumonia Year: 2009 Pro-adrenomedullin, pro-atrial natriuretic peptide and procalcitonin levels at admission in patients with community-acquired pneumonia and its correlation with risk scores Source: Annual Congress 2011 - Biomarkers and outcomes of community-acquired pneumonia Year: 2011 Prognostic power of proadrenomedullin in community-acquired pneumonia is independent of aetiology Source: Eur Respir J 2012; 39: 1144-1155 Year: 2012 Midregional pro-atrial natriuretic peptide and procalcitonin improve survival prediction in VAP Source: Eur Respir J 2011; 37: 595-603 Year: 2011 Thrombocytopenia predicts severity and mortality in CAP – Experience of developing country hospital Source: Annual Congress 2012 - Respiratory infections: prognosis and outcome Year: 2012 B-type natriuretic peptide (BNP) in COPD patients with acute respiratory failure (ARF) Source: Annual Congress 2010 - COPD: cardiovascular comorbidities Year: 2010 N-terminal-pro-B-type natriuretic peptide (NT-proBNP) in patient with acute exacerbations (AE) of COPD Source: Annual Congress 2008 - Biomarkers and disease assessment in COPD Year: 2008 Brain natriuretic peptide (BNP) determination in patients hospitalized for COPD exacerbation Source: Annual Congress 2008 - Biomarkers and disease assessment in COPD Year: 2008 Plaque-related vs. plaque-unrelated cardio and cerebrovascular events (CCVE) in hospitalized patients with community-acquired pneumonia (CAP): Preliminary results from the FAILCAP study (ClinicalTrials: NCT01143155) Source: International Congress 2014 – Immunology of respiratory infections Year: 2014 Procalcitonin and neopterin in community-acquired pneumonia – correlation with microbial aetiology, severity and mortality Source: Annual Congress 2009 - Assessment of severity in respiratory infections: severity scales and biomarkers Year: 2009 Nosocomial pneumonia and non invasive ventilation in a tertiary public hospital – an observational study Source: Annual Congress 2009 - New trends in noninvasive ventilation for acute respiratory failure Year: 2009 Diagnostic value of N-terminal pro-brain natriuretic peptide in patients with COPD with chronic hypoxemic respiratory failure. Source: Virtual Congress 2020 – COPD and the impact of comorbidities Year: 2020 The role of amino-terminal pro-brain natriuretic peptide (NT-proBNP in clinical evaluation of patient with acute exacerbation chronic obstructive pulmonary disease Source: International Congress 2014 – ICU outcomes, sepsis and infections Year: 2014